Explore emerging treatment strategies for multiple myeloma in this comprehensive 57-minute educational video. Delve into crucial topics including mortality rates, cost burden, and randomized studies with lenalidomide-dexamethasone control arms. Examine the DPd regimen in first relapse through the Emory experience and learn how to prepare for CRS and ICANS with BCMA CAR-T constructs. Investigate the antibody landscape, focusing on safety considerations, and review current guidelines. Gain insights into the formulary review process, treatment sequencing, and relapse management. Analyze systemic reviews, cost-effectiveness modeling, and salvage therapies. Discover patient-centered approaches and effective managed care strategies for multiple myeloma treatment. Enhance your understanding of this complex disease and its evolving treatment landscape to improve patient outcomes.
Overview
Syllabus
Intro
Learning Objectives
Mortality
Cost Burden
Randomized Studies With Lenalidomide- Dexamethasone Control Arms
DPd in First Relapse: Emory Experience
Prepare for CRS and ICANS with BCMA CAR-T Constructs
Antibody Landscape: Safety
Guidelines
Formulary Review and the P&T Process
Treatment Sequencing: An Example
Relapse Treatment
Systemic Review
Cost Effectiveness Modeling
Salvage Therapies
Patient-Centered Approach
Managed Care Strategies
Taught by
HMP Education
